Tirzepatide for Obesity Treatment and Diabetes Prevention | New …
Nov 13, 2024 · Obesity is a chronic disease and causal precursor to myriad other conditions, including type 2 diabetes. In an earlier analysis of the SURMOUNT-1 trial, tirzepatide was …
The Emerging Threat of H5N1 to Human Health | New England …
Dec 31, 2024 · Against this background, more humans have come into contact with HPAI A(H5N1). Investigators now report in the Journal a series of human cases from the United …
Management of Insomnia | New England Journal of Medicine
Jul 17, 2024 · Insomnia is common and frequently occurs with other disorders. First-line cognitive behavioral therapy with or without medication can produce rapid, sustained alleviation of …
Continuing Medical Education - The New England Journal of …
The NEJM Weekly CME Program offers one AMA PRA Category 1 Credit™ for each successfully completed Weekly CME or Interactive Medical Case activity. A personal subscription to NEJM …
Daratumumab or Active Monitoring for High-Risk Smoldering …
Dec 9, 2024 · Among the 390 enrolled patients, 194 were assigned to the daratumumab group and 196 to the active-monitoring group. With a median follow-up of 65.2 months, the risk of …
Hemophagocytic Lymphohistiocytosis | New England Journal of …
Feb 5, 2025 · West J, Stilwell P, Liu H, et al. Temporal trends in the incidence of hemophagocytic lymphohistiocytosis: a nationwide cohort study from England 2003-2018. Hemasphere …
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
Feb 7, 2025 · In a phase 3, randomized, controlled trial, we assigned adults with biopsy-proven active lupus nephritis in a 1:1 ratio to receive obinutuzumab in one of two dose schedules …
No. 24 - The New England Journal of Medicine
Explore this issue of The New England Journal of Medicine (Vol. 391 No. 24).
Efficacy and Safety of Acoramidis in Transthyretin Amyloid ...
Jan 10, 2024 · Most of the patients had either New York Heart Association (NYHA) class II symptoms (72.0%) or class III symptoms (17.2%). The distribution of National Amyloidosis …
Perioperative Chemotherapy or Preoperative Chemoradiotherapy …
Jan 22, 2025 · Multimodal Treatment in Locally Advanced Esophageal Adenocarcinoma — Two Interventions Better Than Three?, New England Journal of Medicine, 392, 4, (396-398), …